Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb CofiledCriticalBristol Myers Squibb Co
Priority to DO2005000170ApriorityCriticalpatent/DOP2005000170A/es
Publication of DOP2005000170ApublicationCriticalpatent/DOP2005000170A/es
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
La presente invención está dirigida a un Nuevo método para la prevención o tratamiento de infeciones respiratorias en infants. El método comprende la administración de una cantidad efectiva terapéuticamente de DHA y ARA al infante.
DO2005000170A2005-08-292005-08-29Metodo de prevencion o tratamiento de infeciones respiratorias en infantes
DOP2005000170A
(es)
Use of aclidinium for the manufacture of a drug for use in the treatment or prevention of respiratory illness and pharmacist's preparation for the treatment or prevention of respiratory illness
Tratamiento de transtornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il) benzo[]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma